Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.44 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547256 | 0.84 | ALDH1A1 (0.52) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL9160381 | 0.83 | ALDH1A1 (0.56) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL7505138 | 0.82 | ALDH1A1 (0.55) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL7791465 | 0.82 | HDAC3 (0.51) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL28647892 | 0.82 | ALDH1A1 (0.50) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL7919582 | 0.80 | ALDH1A1 (0.53) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL11287043 | 0.79 | ALDH1A1 (0.58) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL1927016 | 0.79 | ALDH1A1 (0.69) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL380050 | 0.79 | ALDH1A1 (0.76) | ALDH1A1GLATSHRHTTSMN1; SMN2 | |
| SCHEMBL13735234 | 0.79 | ALDH1A1 (0.52) | ALDH1A1GLATSHRHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250229248-A1 | CONTINUOUS-FLOW PREPARATION METHOD OF AMINO ALCOHOL COMPOUNDS | UNIV FUDAN (CN) | 2025-07-17 | — | — | US | disclosed |
| CN-118420478-A | Continuous flow preparation method of amino alcohol compound | 复旦大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-101535303-B | Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level | NOVARTIS AG | 2012-07-18 | — | — | CN | disclosed |
| CN-101535303-A | Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level | NOVARTIS AG (CH) | 2009-09-16 | — | — | CN | disclosed |
| WO-2008053479-A1 | SELF-IMMOLATIVE POLYMERS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250229248-A1 | CONTINUOUS-FLOW PREPARATION METHOD OF AMINO ALCOHOL COMPOUNDS | BCAT2, ADH1C, BCAT1 | ALDH1A1 80/4885GLA 4863/4885TSHR 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.